Rakesh K Singh Selected Research

Heart Diseases (Heart Disease)

11/2020	Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
3/2016	Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Immune Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rakesh K Singh Research Topics

Disease

96	Neoplasms (Cancer) 11/2023 - 11/2002
40	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2003
24	Ovarian Neoplasms (Ovarian Cancer) 10/2022 - 05/2008
22	Breast Neoplasms (Breast Cancer) 11/2023 - 07/2008
13	Infections 03/2024 - 01/2005
12	Melanoma (Melanoma, Malignant) 12/2012 - 04/2002
11	Leishmaniasis 11/2023 - 01/2009
11	Neuroblastoma 01/2022 - 10/2007
8	Endometrial Neoplasms (Endometrial Cancer) 02/2024 - 07/2011
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 09/2010
6	Visceral Leishmaniasis (Kala Azar) 03/2024 - 10/2012
6	COVID-19 03/2023 - 10/2020
6	Inflammation (Inflammations) 01/2023 - 01/2005
5	Carcinogenesis 01/2020 - 01/2014
5	Osteolysis 05/2010 - 07/2008
4	Neuroinflammatory Diseases 01/2020 - 01/2018
4	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2007
4	Hypercalcemia (Milk Alkali Syndrome) 10/2014 - 11/2011
3	Hypertrophy 11/2023 - 01/2020
3	Myocarditis (Carditis) 11/2021 - 03/2016
3	Type 2 Diabetes Mellitus (MODY) 05/2018 - 05/2009
3	Heart Failure 12/2016 - 08/2013
3	Hypoxia (Hypoxemia) 10/2015 - 09/2002
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2004
2	Multiple Organ Failure (MODS) 01/2022 - 11/2020
2	Ischemic Stroke 03/2021 - 07/2017
2	Heart Diseases (Heart Disease) 11/2020 - 03/2016
2	Tuberculosis (Tuberculoses) 01/2020 - 09/2017
2	Arthritis (Polyarthritis) 01/2020 - 06/2019

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
16	CytokinesIBA 03/2024 - 04/2005
15	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
15	LigandsIBA 01/2022 - 01/2003
11	Small Interfering RNA (siRNA)IBA 06/2023 - 10/2005
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
9	ChemokinesIBA 01/2021 - 03/2003
9	Chemokine ReceptorsIBA 01/2021 - 04/2010
7	AntigensIBA 01/2024 - 04/2005
7	VaccinesIBA 11/2023 - 09/2012
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 09/2002
6	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 02/2011
6	Interleukin-8B ReceptorsIBA 01/2020 - 01/2003
6	Interleukin-8 (Interleukin 8)IBA 01/2020 - 04/2002
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015 - 09/2002
6	PlatinumIBA 06/2014 - 05/2008
5	Vitamin D FDA LinkGeneric 06/2023 - 07/2011
5	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 02/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 07/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 09/2017 - 01/2009
4	PolymersIBA 01/2022 - 07/2013
4	Semaphorins (Semaphorin)IBA 02/2021 - 09/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 05/2013
4	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 04/2008
4	AlkaloidsIBA 05/2018 - 01/2009
4	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 11/2015 - 05/2011
4	CopperIBA 10/2015 - 09/2009
4	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 11/2013 - 07/2011
4	Cathepsin GIBA 02/2010 - 07/2008
3	Peptides (Polypeptides)IBA 03/2024 - 01/2007
3	CollagenIBA 11/2023 - 05/2003
3	AntibodiesIBA 11/2023 - 08/2010
3	FlavonoidsIBA 10/2022 - 08/2009
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 04/2016
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 09/2012
3	CholesterolIBA 01/2021 - 05/2018
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2017
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2019 - 01/2018
3	MicellesIBA 01/2019 - 03/2015
3	AntioxidantsIBA 05/2015 - 07/2011
3	Vascular Endothelial Growth Factor CIBA 01/2015 - 10/2005
3	ethyl isothiocyanateIBA 08/2012 - 11/2007
3	7-methyl-indole ethyl isothiocyanateIBA 08/2012 - 11/2007
3	indoleIBA 08/2012 - 11/2007
3	p38 Mitogen-Activated Protein KinasesIBA 04/2012 - 08/2010
3	Iron(III)-salopheneIBA 04/2011 - 05/2008
3	RANK LigandIBA 01/2011 - 07/2008
3	Calcifediol (Calcidiol)FDA Link 10/2010 - 10/2007
3	Matrix Metalloproteinases (MMPs)IBA 05/2010 - 05/2003
2	Interleukin-12 (IL 12)IBA 03/2024 - 11/2011
2	N-(2-chloro-4-pyridyl)-N'-phenylureaIBA 02/2024 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2024 - 04/2023
2	Dyneins (Dynein)IBA 11/2023 - 04/2023
2	ActomyosinIBA 11/2023 - 04/2023
2	ChromatinIBA 06/2023 - 02/2010
2	QuercetinIBA 10/2022 - 05/2015
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022 - 10/2014
2	plexinIBA 02/2021 - 01/2007
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2009
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 10/2015

Therapy/Procedure

41	Therapeutics 06/2023 - 03/2007
13	Drug Therapy (Chemotherapy) 01/2021 - 08/2007
3	Immunotherapy 01/2021 - 08/2009
3	Heart Transplantation (Grafting, Heart) 11/2017 - 07/2013
2	RNAi Therapeutics 01/2022 - 01/2021
2	Thrombectomy 03/2021 - 07/2017
2	Resistance Training 01/2020 - 01/2020
2	Extracorporeal Membrane Oxygenation 01/2020 - 02/2012